Kevin Kinsella3 min read
Tanner Kreger | Ocorian4 min read
Julie DiMauro3 min read
Jean Hurley3 min read
Julie DiMauro43 min listen
GRIP2 min read
Kevin Kinsella3 min read
Tanner Kreger | Ocorian4 min read
Julie DiMauro3 min read

DOJ said two companies tried to drive certain beneficiaries away because their disabilities could make coverage costly.
Julie DiMauro3 min read

At the annual pharmaceutical compliance event, speakers discussed the Gilead False Claims Case and Trump administration initiatives.
Julie DiMauro5 min read

At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.
Julie DiMauro5 min read

We discussed improper marketing strategies, upcoding and billing issues, defense strategies for fraud cases with Tama Kudman and Barry Posner.
Alexander Barzacanos7 min read

Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.
Julie DiMauro3 min read

Pilot program at DOJ will give immunity to executives providing information about corporate misconduct in which they were involved.
Julie DiMauro2 min read

Millions of dollars in bribes were paid to Ecuadorian government officials.
Julie DiMauro3 min read